Existing evidence suggests that Vascular endothelial growth factor-A (VEGF-A) delivery delays the onset and progression of ALS in superoxide dismutase-1 (SOD1) mutated transgenic mouse model by activating PI3-K/Akt anti apoptotic pathway [1,2]. Here, SOD1 is linked to amyotrophic lateral sclerosis.